Video Experimental Relacionado
Updated: May 5, 2026
10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
38.0K
La red transcripcional para la transformación mesenquimal de los tumores cerebrales
Maria Stella Carro1, Wei Keat Lim, Mariano Javier Alvarez
1Institute for Cancer Genetics, Columbia University Medical Center, New York, New York 10032, USA.
Nature
|December 25, 2009
Resumen
Dos factores de transcripción, C/EBPbeta y STAT3, impulsan la transformación mesenquimal en el glioma maligno. Su activación inicia y mantiene este fenotipo tumoral agresivo, ofreciendo objetivos terapéuticos potenciales.
Área de la Ciencia:
- Biología de sistemas Biología de sistemas.
- Investigación de la investigación del cáncer.
- La oncología molecular es una oncología molecular.
Sus antecedentes:
- La agresividad del glioma maligno está relacionada con un fenotipo mesenquimal.
- Las redes reguladoras que impulsan este fenotipo son en gran parte desconocidas.
- Comprender estas redes es crucial para desarrollar terapias dirigidas.
Objetivo del estudio:
- Para identificar los reguladores de la transcripción responsables de la expresión génica mesenquimal en el glioma maligno.
- Aclarar el papel de estos reguladores en el desarrollo y la progresión del glioma.
Principales métodos:
- Ingeniería inversa de las redes reguladoras específicas del glioma.
- Interrogación imparcial de los módulos de transcripción.
- Manipulación experimental de la expresión del factor de transcripción (coexpresión y eliminación).
Principales resultados:
- Se identificó un módulo transcripcional específico que activa los genes mesenquimales.
- C/EBPbeta y STAT3 fueron revelados como reguladores sinérgicos clave de la transformación mesenquimal.
- Coexpresión del linaje mesenquimal inducido por C/EBPbeta y STAT3 en células madre neurales.
- La eliminación de C/EBPbeta y STAT3 redujo la firma mesenquimal y la agresividad en las células de glioma.
- Una alta expresión de C/EBPbeta y STAT3 se correlaciona con la diferenciación mesenquimal y un mal pronóstico en el glioma humano.
Conclusiones:
- Un pequeño módulo regulador, impulsado por C/EBPbeta y STAT3, es necesario y suficiente para iniciar y mantener el fenotipo mesenquimal en las células cancerosas.
- Estos hallazgos destacan C/EBPbeta y STAT3 como factores críticos de la agresividad del glioma y posibles objetivos terapéuticos.
Videos de Conceptos Relacionados
02:23Master Transcription Regulators
6.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
02:30Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K